sirolimus and cyclophosphamide
Phase 2Small molecule
sirolimus and cyclophosphamide is one of 6 small molecule programs targeting Myxoid Liposarcoma. It is currently in Phase 2.
1
Indications
1
Total Trials
0
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
6 competitors in Myxoid Liposarcoma
#DrugCompanyPhaseTrials
1Decadron
AAspen Global Incorporated
Approved
Actos
TakedaPhase 2
Yondelis
AApotex Inc.
Phase 2
Brostallicin
EEuropean Organisation for Research and Treatment of Cancer - EORTC
Phase 2
Efatutazone
AAlliance for Clinical Trials in Oncology
Phase 2
sirolimus and cyclophosphamide
LLeiden University Medical Center
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- LLeiden University Medical Center